Bispecific Antibody Therapy in B-Cell Lymphoma

Bispecific Antibody Therapy in B-Cell Lymphoma

Group photo of four medical professionals including Dr. Joshua Brody, Dr. Sarah Rutherford, Dr. Rohit Gosain, and Dr. Rahul Gosain, discussing managing side effects of bispecific antibodies for B-cell.

Bispecific Antibody Therapy in B-Cell Lymphoma

09/08/2026

Ep. 2: Managing Adverse Effects of Bispecific Antibodies for B-Cell Lymphoma

Joshua Brody, MDSarah Rutherford, MDRahul Gosain, MD, MBARohit Gosain, MD

Group photo of four medical professionals discussing B-cell lymphomas for OncUpdates.

Bispecific Antibody Therapy in B-Cell Lymphoma

09/02/2026

Ep. 1: Bispecific Antibody Options for Relapsed or Refractory B-Cell Lymphomas

Joshua Brody, MDSarah Rutherford, MDRahul Gosain, MD, MBARohit Gosain, MD

Team of medical researchers discussing bispecific antibody therapy for B-cell lymphoma at OncUpdates.

Bispecific Antibody Therapy in B-Cell Lymphoma

08/22/2026

Making a Case for Bispecific Antibody Therapy in B-Cell Lymphoma

Joshua Brody, MDSarah Rutherford, MDRahul Gosain, MD, MBARohit Gosain, MD